|
Volumn 9, Issue 1, 2007, Pages 62-
|
The NEFA study: results at three years.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2',3' DIDEOXYNUCLEOSIDE DERIVATIVE;
ABACAVIR;
ANTIVIRUS AGENT;
BENZOXAZINE DERIVATIVE;
EFAVIRENZ;
NEVIRAPINE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
FOLLOW UP;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
KAPLAN MEIER METHOD;
RANDOMIZED CONTROLLED TRIAL;
TIME;
ANTIVIRAL AGENTS;
BENZOXAZINES;
DIDEOXYNUCLEOSIDES;
FOLLOW-UP STUDIES;
HIV INFECTIONS;
HUMANS;
KAPLAN-MEIERS ESTIMATE;
NEVIRAPINE;
RANDOMIZED CONTROLLED TRIALS;
TIME FACTORS;
|
EID: 34347389953
PISSN: 11396121
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|